AURO PEPTIDES LIMITED

Active

AURO PEPTIDES LIMITED having CIN U24232TG2012PLC078350 is 13 years , 5 month & 10 days old Public Indian Company incorporated on 02 Jan 2012. It is classified as Non-government company and is registered at ROC Hyderabad. Its authorized share capital is Rs. 3,001,000,000 and its paid up capital is Rs. 2,478,500,000. It's NIC code is 24232 (which is part of its CIN).

As per the NIC code, it is involved in Manufacture Of Allopathic Pharmaceutical Preparations . AURO PEPTIDES LIMITED Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 08-21-2023. Directors of AURO PEPTIDES LIMITED are Mudiraj Saritha Rani and Mudiraj Saritha Rani.

AURO PEPTIDES LIMITED ' Corporate Identification Number (CIN) is U24232TG2012PLC078350 and its registration number is 078350. Users may contact AURO PEPTIDES LIMITED on its Email address - cs@aurobindo.com Registered address of AURO PEPTIDES LIMITED is Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak,Hyderabad,Telangana,India-500032. Current status of AURO PEPTIDES LIMITED is - Active.

Key Indicators

Authorised Capital

3,001,000,000

as on 12/06/2025

Paid Up Capital

2,478,500,000

as on 12/06/2025

Company Age

13 Year, 5 Months

Last Filing with ROC

1 Year, 9 Months

CIN	U24232TG2012PLC078350
Company Status	Active
Registration Number	078350
Date of Incorporation	01/02/2012
RoC	ROC Hyderabad
Company Age	13 years & 165 days
Authorized Capital	₹ 3001000000
Paid-up capital	₹ 2478500000
Company Category	Company limited by shares
Company Sub-Category	Non-government company
Class of company	Public
Activity	Manufacture Of Allopathic Pharmaceutical Preparations
Listing status	Unlisted
Date of Last Annual General Meeting	31-03-2023
Date of Latest Balance Sheet	31-03-2023

Contact

Email ID	cs@aurobindo.com
Address	Near Kavuri Hills Junction Madhapur Hyderabad Telangana India 500081
Website	aurobindo.com
Contact Number	+91*******

Location on Map

Director

Designation	Name	Date OF Appointment	DIN	PAN	Tenure
Director	SIVAKUMARAN MEENAKSHISUNDERAM	08/27/2018	01284320	*****7178A	6 years
Director	. SAPNA	03/08/2023	08434059	*****0511H	2 years
Director	VENKATESWARARAO KONDREDDY	11/08/2023	02907769		1 years
Director	VINOD KUMAR REDDY AERVA	08/22/2016	02944453	*****2331G	8 years
Director	SATAKARNI MAKKAPATI	02/16/2023	09377266	*****4130H	2 years
Director	CHANDRA REDDY TIRUMALAREDDY	11/21/2023	08432430	*****7105L	1 years
Director	MUDIRAJ SARITHA RANI	08/22/2023	07265096	*****8884E	1 years
Director	. SINGHAL SHILPA	06/20/2022	09631023	*****6291K	2 years
Director	SUBBARAO NAGA VENKATA KESAVARAPU	02/24/2023	08148749	*****6073K	2 years
Director	MYLANDLAHALLI RAMMOHAN ASHWINI	03/21/2024	10568862	*****6968M	1 years

Companies connected through Directors

Name	Status	Paid Up Capital	Common Directors	Address
CURATEQ BIOLOGICS PRIVATE LIMITED	Active	1,00,00,00,000.00	1	Telangana
APL RESEARCH CENTRE LIMITED	Amalgamated	12,26,00,000.00	1	Telangana
AUROACTIVE PHARMA PRIVATE LIMITED	Active	1,00,00,00,000.00	1	Telangana
AUROBINDO PHARMA FOUNDATION	Active	1,00,000.00	1	Telangana
AUROZYMES LIMITED	Amalgamated	5,00,000.00	1	Telangana
TRIDENT LIFE SCIENCES LIMITED	Amalgamated	1,60,000.00	1	Telangana
APL HEALTHCARE LIMITED	Active	2,22,00,00,000.00	1	Telangana
EUGIA STERILES PRIVATE LIMITED	Active	44,25,00,000.00	1	Telangana
CUREPRO PARENTERALS LIMITED	Amalgamated	13,31,01,070.00	1	Telangana
AURONEXT PHARMA PRIVATE LIMITED	Amalgamated	1,24,98,40,280.00	2	Telangana
HYACINTHS PHARMA PRIVATE LIMITED	Amalgamated	32,50,00,000.00	2	Telangana
RAIDURGAM DEVELOPERS LIMITED	Active	10,00,00,000.00	2	Telangana
SUCCESS MANTRA BUSINESS SOLUTIONS PRIVATE LIMITED	Active	1,00,000.00	1	Telangana
AURO VACCINES PRIVATE LIMITED	Active	10,00,000.00	2	Telangana
EUGIA SEZ PRIVATE LIMITED	Active	3,38,00,00,000.00	1	Telangana

Charges on assets

No Data Available

Charge Holder	Branch	Amount	Date of creation	Modification	Satisfaction	Status
Not Available

Registered Details

CIN

U24232TG2012PLC078350

PAN

U24232TG2012PLC078350

Incorporation

1 years , 2 month

Company Email

cs@aurobindo.com

Paid up Capital

₹ 2,478,500,000

Authorised Capital

₹ 3,001,000,000

Type

Public Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

Industry

Manufacture Of Allopathic Pharmaceutical Preparations

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales

9.29%

₹ 0

EBITDA

29%

₹ 0

Net Profit

29%

₹ 0

Networth

29%

₹ 0

Borrowings

9.29%

₹ 0

Assets

9.29%

₹ 0

Gross Margin

9.29%

₹ 0

Operating Margin

29%

₹ 0

Net Profit Margin

29%

₹ 0

Return on Equity

29%

₹ 135,987.4

ROCE

9.29%

₹ 140,987.4

Debt to Equity

9.29%

₹ 0

Financial Highlights

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales
Operating profit
Net profit
Gross margin
Operating margin
Net margin
Networth
Borrowings
Assets
Debt to equity
Current ratio
ROE
Days payable
WC days

Balance Sheet

**** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds +
(a) Share capita
(b) Reserves and surplus
(c) Money received against share warrants
(2) Share application money pending allotment
(3) Non-current liabilities +
(a) Long-term borrowings
(b) Deferred tax liabilities (Net)
(c) Other Long-term liabilities
(d) Long-term provisions
(4) Current liabilities +
(a) Short-term borrowings
(b) Trade payables
(A) total outstanding dues of micro enterprises and small enterprises; and
(B) total outstanding dues of creditors other than micro enterprises and small enterprises.
(c) Other current liabilities
(d) Short-term provisions
Total
ASSETS
Non-current assets +
(a) [Property, Plant and Equipment]
(i) Tangible assets
(ii) Intangible assets
(iii)Capital work-in-progress
(iv) Intangible assets under development
(b) Non-current investments
(c) Deferred tax assets (net)
(d) Long-term loans and advances
(e) Other non-current assets
(2) Current assets +
(a) Current investments
(b) Inventories
(c) Trade receivables
(d) Cash and cash equivalents
(e) Short-term loans and advances
(f) Other current assets
Total assets

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds +
(a) Share capita
(b) Reserves and surplus
(c) Money received against share warrants
(2) Share application money pending allotment
(3) Non-current liabilities +
(a) Long-term borrowings
(b) Deferred tax liabilities (Net)
(c) Other Long-term liabilities
(d) Long-term provisions
(4) Current liabilities +
(a) Short-term borrowings
(b) Trade payables
(A) total outstanding dues of micro enterprises and small enterprises; and
(B) total outstanding dues of creditors other than micro enterprises and small enterprises.
(c) Other current liabilities
(d) Short-term provisions
Total
ASSETS
Non-current assets +
(a) [Property, Plant and Equipment]
(i) Tangible assets
(ii) Intangible assets
(iii)Capital work-in-progress
(iv) Intangible assets under development
(b) Non-current investments
(c) Deferred tax assets (net)
(d) Long-term loans and advances
(e) Other non-current assets
(2) Current assets +
(a) Current investments
(b) Inventories
(c) Trade receivables
(d) Cash and cash equivalents
(e) Short-term loans and advances
(f) Other current assets
Total assets

Profit & Loss

**** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
I.Revenue from operations
II. Other income
III.Total Revenue (I + II)
IV.Expenses +
(1)Cost of materials consumed
(2)Purchases of Stock-in-Trade
(3)Changes in inventories of finished goods work-in-progress and
(4)Stock-in-Trade
(5)Employee benefits expense
(6)Finance costs
(7)Depreciation and amortisation expense
(8)Other expenses
(9)Total expenses
VProfit before exceptional and extraordinary items and tax (III - IV)
VIExceptional items
VII.Profit before extraordinary items and tax (V - VI)
VIII.Extraordinary items
IX.Profit before tax (VII- VIII)
X. Tax expense: +
(1)Current tax
(2)Deferred tax
XI.Profit (Loss) for the period from continuing operations (VII-VIII)
XII.Profit/(loss) from discontinuing operations
XIII.Tax expense of discontinuing operations
XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII)
XV.Profit (Loss) for the period (XI + XIV)
XVI.Earnings per equity share: +
(1) Basic
(2)Diluted

Precentage of total incomex
Sales +
Sales growth %
Expenses +
Cost of services
Employee benefits expense
Other costs
Operating profit +
Operating margin %
Other income
Interest
Depreciation
Exceptional items
Profit before tax
Tax
Profit - disc. ops
Net profit
Net margin %

Ratio

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Solvency +	0.00	0.00	0.00	0.00	0.00
Total Debt/Equity	0.00	0.00	0.00	0.00	0.00
Net Debt/Equity	0.00	0.00	0.00	0.00	0.00
Total Debt/Assets	0.00	0.00	0.00	0.00	0.00
Total Assets/Equity	0.00	0.00	0.00	0.00	0.00
Liquidity +	0.00	0.00	0.00	0.00	0.00
Current Ratio	0.00	0.00	0.00	0.00	0.00
Quick Ratio	0.00	0.00	0.00	0.00	0.00
Interest Coverage	0.00	0.00	0.00	0.00	0.00
Performance	0.00	0.00	0.00	0.00	0.00
Gross Margin	0.00	0.00	0.00	0.00	0.00
Operating Margin	0.00	0.00	0.00	0.00	0.00
Net Margin	0.00	0.00	0.00	0.00	0.00
Return +	0.00	0.00	0.00	0.00	0.00
Return on Equity	0.00	0.00	0.00	0.00	0.00
Pre-tax ROCE	0.00	0.00	0.00	0.00	0.00
Return on Assets	0.00	0.00	0.00	0.00	0.00
Pre-tax ROIC	0.00	0.00	0.00	0.00	0.00
Efficiency +	0.00	0.00	0.00	0.00	0.00
Days Payable	0.00	0.00	0.00	0.00	0.00
Days Inventory	0.00	0.00	0.00	0.00	0.00
Days Receivable	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00
Total Asset Turnover	0.00	0.00	0.00	0.00	0.00
Working Capital	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle	0.00	0.00	0.00	0.00	0.00
Working Capital Days	0.00	0.00	0.00	0.00	0.00

Subsidiaries, Associate Companies & Join Ventures of Auro Peptides Limited

Company Identifier	Name	Percentage of Shares Held

Fund Raising Activity of Auro Peptides Limited

Date of Allotment	Securities Alloted	Terms	Number of Securities	Nominal Amount	Premium Amount Due & Payable	Premium Amount Paid	Total Discount	Amount to be Paid on Calls (Excluding Premium)	Attachments

Board Meetings of Auro Peptides Limited

Date of Filing	Date of Dispatch of Notice	Date of Passing Resolution	Section (Companies Act 2013)	Section (Companies Act 1956)	Subject Matter of Resolution	Resolution Agreed By	Resolution Type	Additional Documents

Auditors of Auro Peptides Limited

Financial Year	Name of Auditor or Firm	PAN of Auditor or Firm	Membership Number / Registration Number	Name of Auditor Signing Report	Membership Number of Auditor Signing Report

Outstanding Payments to Micro & Small Enterprises

Filing Type	As On	Amount Due to MSME	Current Liabilities	Ratio to Current Liabilities	Reasons for Delay

Investor Complaints & Serious Complaints About Auro Peptides Limited

Director Complain

Date	DIN	Cessation Date	Cessation Reason	Complaint

Serious Complaints

Date	Complaint	Other

Investor Complaints & Other Complaints

Date	Complaint Type	Complaint Sub Type	Particulars of Secutiries	Period	Complaint	Other Details

Prosecution Details of Auro Peptides Limited

S.No.	Defaulting Entities	Court Name	Prosecution Section	Date of Order	Status

FAQs- Auro Peptides Limited

What is AURO PEPTIDES LIMITED ?

AURO PEPTIDES LIMITED having CIN U24232TG2012PLC078350 is 1 years , 2 month old Public Indian Company incorporated with MCA on 21 Mar 2024. AURO PEPTIDES LIMITED is listed in the class of Public Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Hyderabad with an Authorized Share Capital of 3,001,000,000 and paid-up capital is 2,478,500,000.

What is the CIN of AURO PEPTIDES LIMITED?

CIN of AURO PEPTIDES LIMITED is U24232TG2012PLC078350.

Where is AURO PEPTIDES LIMITED located?

Address of AURO PEPTIDES LIMITED is Galaxy, floors 22-24, plot no. 1, survey no. 83/1 hyderabad knowledge city, raidurg panmak,hyderabad,telangana,india-500032,.

Who are the directors of AURO PEPTIDES LIMITED ?

The company has 21 directors/key management personnel Sivakumaran Meenakshisunderam,. Sapna,sandeep Gourishetti,venkateswararao Kondreddy,vinod Kumar Reddy Aerva,satakarni Makkapati,chandra Tirumalareddy,mudiraj Rani,. Singhal Shilpa,vishwanathan Cheneerkupam,satakarni Makkapati,. Sapna,subbarao Kesavarapu,vijayudu Gajulapalli,naga Venkata Kesavarapu,u24232tg2012plc078350 U24232tg2012plc078350,mylandlahalli Ashwini,mylandlahalli Ashwini,chandra Tirumalareddy,venkateswararao Kondreddy,mudiraj Rani,

What is the contact details of AURO PEPTIDES LIMITED ?

Email : cs@aurobindo.com
Address : Near Kavuri Hills Junction Madhapur Hyderabad Telangana India 500081

What does AURO PEPTIDES LIMITED do?

AURO PEPTIDES LIMITED is involved in activities such as Computer programming, consultancy and related activities

Popular Services

Spice Board registration APEDA Registration Importer Exporter Code Registration AD Code Registration ESI Registration FSSAI Registration FCRA Registration FCRA Registration for Trusts FCRA Registration for Societies FCRA Registration for Section 8 Company Import Export Code Import Export Code Process NSIC Registration Private Limited Company Limited Liability Partnership Partnership Firm One Person Company Startup India Registration PF Registration Director KYC Auditor's Appointment Director's Appointment Net worth Certificate Labour License LLP Annual Compliance Filing